These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10918198)

  • 1. A3--a novel colon and pancreatic cancer reactive antibody from a primate phage library selected using intact tumour cells.
    Tordsson J; Lavasani S; Ohlsson L; Karlström P; Svedberg H; Abrahmsén L; Brodin T
    Int J Cancer; 2000 Aug; 87(4):559-68. PubMed ID: 10918198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma.
    Tordsson JM; Ohlsson LG; Abrahmsén LB; Karlström PJ; Lando PA; Brodin TN
    Cancer Immunol Immunother; 2000 Mar; 48(12):691-702. PubMed ID: 10752477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel tumor-specific human single-chain Fv selected from an active specific immunotherapy phage display library.
    Hall BL; Boroughs J; Kobrin BJ
    Immunotechnology; 1998 Oct; 4(2):127-40. PubMed ID: 9853954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
    Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
    Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen.
    Forsberg G; Ohlsson L; Brodin T; Björk P; Lando PA; Shaw D; Stern PL; Dohlsten M
    Br J Cancer; 2001 Jul; 85(1):129-36. PubMed ID: 11437414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody.
    Ueno A; Arakawa F; Abe H; Matsumoto H; Kudo T; Asano R; Tsumoto K; Kumagai I; Kuroki M; Kuroki M
    Anticancer Res; 2002; 22(2A):769-76. PubMed ID: 12014649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterisation of a monovalent and bivalent form of a fully human anti Ep-CAM phage antibody.
    Roovers RC; van der Linden E; de Bruïne AP; Arends JW; Hoogenboom HR
    Cancer Immunol Immunother; 2001 Mar; 50(1):51-9. PubMed ID: 11315510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies.
    Gidlöf C; Dohlsten M; Lando P; Kalland T; Sundström C; Tötterman TH
    Blood; 1997 Mar; 89(6):2089-97. PubMed ID: 9058731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-chain antibodies in pancreatic cancer.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Batra SK
    Ann N Y Acad Sci; 1999 Jun; 880():263-80. PubMed ID: 10415872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of established colon cancer xenografts using a novel humanized single chain antibody-streptococcal superantigen fusion protein targeting the 5T4 oncofetal antigen.
    Patterson KG; Dixon Pittaro JL; Bastedo PS; Hess DA; Haeryfar SM; McCormick JK
    PLoS One; 2014; 9(4):e95200. PubMed ID: 24736661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
    Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
    BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of tumor-specific internalizing human antibodies from phage libraries.
    Poul MA; Becerril B; Nielsen UB; Morisson P; Marks JD
    J Mol Biol; 2000 Sep; 301(5):1149-61. PubMed ID: 10966812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting.
    Roovers RC; Henderikx P; Helfrich W; van der Linden E; Reurs A; de Bruïne AP; Arends JW; de Leij L; Hoogenboom HR
    Br J Cancer; 1998 Dec; 78(11):1407-16. PubMed ID: 9836471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient selection of scFv antibody phage by adsorption to in situ expressed antigens in tissue sections.
    Tordsson J; Abrahmsén L; Kalland T; Ljung C; Ingvar C; Brodin T
    J Immunol Methods; 1997 Dec; 210(1):11-23. PubMed ID: 9502581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of human colon cancer by antibody-targeted superantigens.
    Dohlsten M; Lando PA; Björk P; Abrahmsén L; Ohlsson L; Lind P; Kalland T
    Cancer Immunol Immunother; 1995 Sep; 41(3):162-8. PubMed ID: 7553685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
    Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U
    Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A melanoma-specific VH antibody cloned from a fusion phage library of a vaccinated melanoma patient.
    Cai X; Garen A
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6280-5. PubMed ID: 8692806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.
    Nakatsura T; Senju S; Ito M; Nishimura Y; Itoh K
    Eur J Immunol; 2002 Mar; 32(3):826-36. PubMed ID: 11870627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells.
    Riesbeck K; Billström A; Tordsson J; Brodin T; Kristensson K; Dohlsten M
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):675-82. PubMed ID: 9729535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.